AMF Tjänstepension’s NovoCure NVCR Stock Holding History

AMF Tjänstepension’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-45,755	Closed	-$2.75M	–	235
2023 Q1	$2.75M	Hold	45,755	–	–	0.03%	192
2022 Q4	$3.36M	Hold	45,755	–	–	0.04%	187
2022 Q3	$3.48M	Sell	45,755 -24,953	-35%	-$1.95M	0.04%	182
2022 Q2	$4.91M	Buy	+70,708	New	+$5.33M	0.05%	187
2021 Q3	–	Sell	-58,696	Closed	-$13M	–	202
2021 Q2	$13M	Buy	+58,696	New	+$11.4M	0.09%	173

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return

AMF Tjänstepension's NVCR Position: Q2 2023 in Review

AMF Tjänstepension sold out of NovoCure (NVCR) in Q2 2023, closing a stake of 45,755 shares — an estimated $2.75M sold.

AMF Tjänstepension first reported a position in NVCR in Q2 2021 and held it in 5 quarters. The position peaked at $13M in Q2 2021. 267 funds tracked by Wall St. Rank hold NVCR as of Q2 2023.

AMF Tjänstepension reported no remaining NovoCure position as of Q2 2023 after selling out during the quarter.
AMF Tjänstepension sold 45,755 NovoCure shares in Q2 2023, an estimated $2.75M.
AMF Tjänstepension first reported a position in NovoCure in Q2 2021 and held it in 5 quarters.
AMF Tjänstepension's NovoCure position peaked at $13M in Q2 2021.
267 funds tracked by Wall St. Rank held NovoCure as of Q2 2023.

Based on AMF Tjänstepension's 13F filing for Q2 2023, filed 5 Jul 2023.